Now may not be the right time for everyone to invest, but a CD remains an excellent choice for some. Find out why.

CD rates are dropping like flies. Learn when it's worth getting a long-term CD and when you're better off with other ...

You may feel heartbroken that you (likely) don’t qualify for Flagler’s CD, but don’t get too hung up on that 10% APY. If you ...

CD rates have been high for the last two years. But will they remain so now, post-rate cut? Here's what to know.

Business CDs are like regular CDs—they can help you earn more on your business savings. Learn how they work and whether ...

On the whole, they can be a financially conservative balance to your portfolio. If you aim to buy CDs, it’s essential to know market trends and interest rates. When rates are expected to rise ...

CDs give artists greater royalties than Spotify, are more durable than vinyl - and their old-school aesthetic is even ...

The celeb chef calls these 'the Rolls-Royce of pans' — they combine the best traits of stainless steel, cast iron and ...

Private equity firm Clayton Dubilier & Rice (CD&R) is nearing a deal to acquire Sanofi's consumer health unit for about 15 ...

Though trendy now, these cultural snapshots are guaranteed to become vintage gems years down the line. There’s no telling how ...

Clayton Dubilier & Rice is nearing a deal to acquire Sanofi’s consumer health unit for about €15 billion ($16.4 billion), in ...

Clayton Dubilier & Rice (CD&R) has entered negotiations to acquire a 50 percent controlling stake in Sanofi’s consumer healthcare business Opella.